Yüklüyor......
Characterization of the Effect of Upadacitinib on the Pharmacokinetics of Bupropion, a Sensitive Cytochrome P450 2B6 Probe Substrate
This phase 1 study characterized the effect of multiple doses of upadacitinib, an oral Janus kinase 1 selective inhibitor, on the pharmacokinetics of the cytochrome P450 (CYP) 2B6 substrate bupropion. Healthy subjects (n = 22) received a single oral dose of bupropion 150 mg alone (study period 1) an...
Kaydedildi:
| Yayımlandı: | Clin Pharmacol Drug Dev |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7984436/ https://ncbi.nlm.nih.gov/pubmed/32648334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.844 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|